• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RAS 蛋白的翻译后修饰。

Posttranslational Modifications of RAS Proteins.

机构信息

Department of Medicine, Perlmutter Cancer Center, New York University School of Medicine, New York, New York 10016.

出版信息

Cold Spring Harb Perspect Med. 2018 Nov 1;8(11):a031484. doi: 10.1101/cshperspect.a031484.

DOI:10.1101/cshperspect.a031484
PMID:29311131
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6035883/
Abstract

The three human genes encode four proteins that play central roles in oncogenesis by acting as binary molecular switches that regulate signaling pathways for growth and differentiation. Each is subject to a set of posttranslational modifications (PTMs) that modify their activity or are required for membrane targeting. The enzymes that catalyze the various PTMs are potential targets for anti-RAS drug discovery. The PTMs of RAS proteins are the focus of this review.

摘要

这三个人类基因编码四种蛋白质,它们作为二元分子开关,通过调节生长和分化信号通路,在致癌作用中发挥核心作用。每一种都受到一组翻译后修饰(PTM)的影响,这些修饰改变了它们的活性或对膜靶向是必需的。催化各种 PTM 的酶是抗 RAS 药物发现的潜在靶点。RAS 蛋白的 PTM 是本综述的重点。

相似文献

1
Posttranslational Modifications of RAS Proteins.RAS 蛋白的翻译后修饰。
Cold Spring Harb Perspect Med. 2018 Nov 1;8(11):a031484. doi: 10.1101/cshperspect.a031484.
2
Effects of Crosstalks Between Sumoylation and Phosphorylation in Normal Cellular Physiology and Human Diseases.SUMO化与磷酸化之间的串扰在正常细胞生理和人类疾病中的作用。
Curr Mol Med. 2017;16(10):906-913. doi: 10.2174/1566524016666161223105555.
3
Post-translational modification of RAS proteins.RAS 蛋白的翻译后修饰。
Curr Opin Struct Biol. 2021 Dec;71:180-192. doi: 10.1016/j.sbi.2021.06.015. Epub 2021 Aug 6.
4
A posttranslational modification cascade drives RAS-induced senescence.翻译后的文本:翻译后内容
Cancer Discov. 2013 Jul;3(7):OF28. doi: 10.1158/2159-8290.CD-RW2013-111. Epub 2013 May 23.
5
Cell-permeable CaaX-peptides affect K-Ras downstream signaling and promote cell death in cancer cells.细胞渗透性 CaaX 肽影响 K-Ras 下游信号转导并促进癌细胞死亡。
FEBS J. 2021 May;288(9):2911-2929. doi: 10.1111/febs.15612. Epub 2020 Nov 7.
6
Post-translational modification of KRAS: potential targets for cancer therapy.KRAS的翻译后修饰:癌症治疗的潜在靶点
Acta Pharmacol Sin. 2021 Aug;42(8):1201-1211. doi: 10.1038/s41401-020-00542-y. Epub 2020 Oct 21.
7
HDAC6 and SIRT2 regulate the acetylation state and oncogenic activity of mutant K-RAS.组蛋白去乙酰化酶 6 和 SIRT2 调节突变型 K-RAS 的乙酰化状态和致癌活性。
Mol Cancer Res. 2013 Sep;11(9):1072-7. doi: 10.1158/1541-7786.MCR-13-0040-T. Epub 2013 May 30.
8
Unconventional posttranslational modification in innate immunity.先天免疫中的非传统翻译后修饰。
Cell Mol Life Sci. 2024 Jul 6;81(1):290. doi: 10.1007/s00018-024-05319-8.
9
Ras proteins as therapeutic targets.Ras 蛋白作为治疗靶点。
Biochem Soc Trans. 2018 Oct 19;46(5):1303-1311. doi: 10.1042/BST20170529. Epub 2018 Aug 28.
10
Regulation of p21ras activity.p21ras活性的调控
Trends Genet. 1991 Nov-Dec;7(11-12):346-51. doi: 10.1016/0168-9525(91)90253-m.

引用本文的文献

1
A versatile enzymatic pathway for modification of peptide C-termini.一种用于修饰肽C末端的多功能酶促途径。
bioRxiv. 2025 Jul 16:2025.07.11.664356. doi: 10.1101/2025.07.11.664356.
2
The ubiquitin code of RAS proteins: Decoding its role in cancer progression.RAS蛋白的泛素密码:解读其在癌症进展中的作用。
iScience. 2025 Jul 1;28(8):113029. doi: 10.1016/j.isci.2025.113029. eCollection 2025 Aug 15.
3
Blocking C-terminal processing of KRAS4b via a direct covalent attack on the CaaX-box cysteine.通过对CaaX盒半胱氨酸进行直接共价攻击来阻断KRAS4b的C端加工。
Proc Natl Acad Sci U S A. 2025 May 13;122(19):e2410766122. doi: 10.1073/pnas.2410766122. Epub 2025 May 9.
4
Loss of Golga7 Suppresses Oncogenic Nras-Driven Leukemogenesis without Detectable Toxicity in Adult Mice.高尔基体蛋白7缺失可抑制致癌性Nras驱动的白血病发生,且对成年小鼠无明显毒性。
Adv Sci (Weinh). 2025 May;12(18):e2412208. doi: 10.1002/advs.202412208. Epub 2025 Mar 17.
5
Pioneer in Molecular Biology: Conformational Ensembles in Molecular Recognition, Allostery, and Cell Function.分子生物学先驱:分子识别、别构效应及细胞功能中的构象集合体
J Mol Biol. 2025 Jun 1;437(11):169044. doi: 10.1016/j.jmb.2025.169044. Epub 2025 Feb 25.
6
ZDHHC18 promotes renal fibrosis development by regulating HRAS palmitoylation.ZDHHC18通过调节HRAS棕榈酰化促进肾纤维化发展。
J Clin Invest. 2025 Feb 4;135(6):e180242. doi: 10.1172/JCI180242.
7
Positive feedback loop between NRAS mutation and RAB27B expression in endothelial cells.内皮细胞中NRAS突变与RAB27B表达之间的正反馈回路。
Biochem Biophys Res Commun. 2025 Mar 1;750:151422. doi: 10.1016/j.bbrc.2025.151422. Epub 2025 Jan 31.
8
Dynamic Multilevel Regulation of EGFR, KRAS, and MYC Oncogenes: Driving Cancer Cell Proliferation Through (Epi)Genetic and Post-Transcriptional/Translational Pathways.表皮生长因子受体(EGFR)、KRAS和MYC癌基因的动态多级调控:通过(表观)遗传及转录后/翻译途径驱动癌细胞增殖
Cancers (Basel). 2025 Jan 14;17(2):248. doi: 10.3390/cancers17020248.
9
Anti-proteolytic regulation of KRAS by USP9X/NDRG3 in KRAS-driven cancer development.USP9X/NDRG3对KRAS的抗蛋白水解调节在KRAS驱动的癌症发展中的作用
Nat Commun. 2025 Jan 16;16(1):628. doi: 10.1038/s41467-024-54476-8.
10
Mebendazole effectively overcomes imatinib resistance by dual-targeting BCR/ABL oncoprotein and β-tubulin in chronic myeloid leukemia cells.甲苯咪唑通过双重靶向慢性髓性白血病细胞中的BCR/ABL癌蛋白和β-微管蛋白有效克服伊马替尼耐药性。
Korean J Physiol Pharmacol. 2025 Jan 1;29(1):67-81. doi: 10.4196/kjpp.24.176. Epub 2024 Nov 14.

本文引用的文献

1
Regulation of NOTCH signaling by RAB7 and RAB8 requires carboxyl methylation by ICMT.RAB7和RAB8对NOTCH信号通路的调控需要ICMT进行羧基甲基化。
J Cell Biol. 2017 Dec 4;216(12):4165-4182. doi: 10.1083/jcb.201701053. Epub 2017 Oct 19.
2
Protein palmitoylation: Palmitoyltransferases and their specificity.蛋白质棕榈酰化:棕榈酰转移酶及其特异性。
Exp Biol Med (Maywood). 2017 Jun;242(11):1150-1157. doi: 10.1177/1535370217707732. Epub 2017 May 9.
3
Multivalent Small-Molecule Pan-RAS Inhibitors.多价小分子泛RAS抑制剂
Cell. 2017 Feb 23;168(5):878-889.e29. doi: 10.1016/j.cell.2017.02.006.
4
Isoprenylcysteine carboxylmethyltransferase is critical for malignant transformation and tumor maintenance by all RAS isoforms.异戊烯基半胱氨酸羧甲基转移酶对于所有RAS亚型的恶性转化和肿瘤维持至关重要。
Oncogene. 2017 Jul 6;36(27):3934-3942. doi: 10.1038/onc.2016.508. Epub 2017 Feb 13.
5
Inhibition of Isoprenylcysteine Carboxylmethyltransferase Induces Cell-Cycle Arrest and Apoptosis through p21 and p21-Regulated BNIP3 Induction in Pancreatic Cancer.异戊二烯基半胱氨酸羧甲基转移酶的抑制通过p21及p21调节的BNIP3诱导在胰腺癌中引发细胞周期停滞和凋亡。
Mol Cancer Ther. 2017 May;16(5):914-923. doi: 10.1158/1535-7163.MCT-16-0703. Epub 2017 Feb 6.
6
Gene Essentiality Profiling Reveals Gene Networks and Synthetic Lethal Interactions with Oncogenic Ras.基因必需性分析揭示基因网络以及与致癌性Ras的合成致死相互作用。
Cell. 2017 Feb 23;168(5):890-903.e15. doi: 10.1016/j.cell.2017.01.013. Epub 2017 Feb 2.
7
Lipid-Sorting Specificity Encoded in K-Ras Membrane Anchor Regulates Signal Output.K-Ras膜锚定区编码的脂质分选特异性调节信号输出。
Cell. 2017 Jan 12;168(1-2):239-251.e16. doi: 10.1016/j.cell.2016.11.059. Epub 2016 Dec 29.
8
Inhibition of Ras/Raf/MEK/ERK Pathway Signaling by a Stress-Induced Phospho-Regulatory Circuit.应激诱导的磷酸调节回路对Ras/Raf/MEK/ERK信号通路的抑制作用
Mol Cell. 2016 Dec 1;64(5):875-887. doi: 10.1016/j.molcel.2016.10.029. Epub 2016 Nov 23.
9
Structural basis of recognition of farnesylated and methylated KRAS4b by PDEδ.PDEδ对法尼基化和甲基化KRAS4b识别的结构基础
Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):E6766-E6775. doi: 10.1073/pnas.1615316113. Epub 2016 Oct 17.
10
AMPK and Endothelial Nitric Oxide Synthase Signaling Regulates K-Ras Plasma Membrane Interactions via Cyclic GMP-Dependent Protein Kinase 2.AMPK与内皮型一氧化氮合酶信号传导通过环磷酸鸟苷依赖性蛋白激酶2调节K-Ras与质膜的相互作用。
Mol Cell Biol. 2016 Nov 28;36(24):3086-3099. doi: 10.1128/MCB.00365-16. Print 2016 Dec 15.